Frequently Asked Questions Core Med Science For Youth Read More about Core Med Science View all
A randomized Phase II clinical trial confirmed that the triple therapy combination of an anti-PD-1 antibody (Sintilimab), an HDAC inhibitor (Citarinostat), and an anti-VEGF antibody (Bevacizumab) demonstrated significant clinical efficacy in colorectal cancer
Cyanocobalamin is the most common and least expensive synthetic form, and your body converts it into an active form
Peptide purity by chromatography tells you about the ligand and says nothing about how much metal is present or how much of it is coordinated
Hands require washing after application to prevent unwanted facial hair growth, particularly important for women
Meet With One of Our Treatment Specialists We'll answer any questions you have, explain our treatments in detail, and create a customized treatment plan just for you